Transdermal Nicotine Patch (2017-12-12)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 1188889 | Transdermal Nicotine Patch | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Actavis Laboratories UT, Inc.
- 575 Chipeta Way
- Salt Lake City
- 84108
- Utah
- UNITED STATES
| Transdermal Patch | NPN 80044389 | 21MG |
Affected products
Transdermal Nicotine Patch
Release liners are defective in affected lot.
Wholesalers (Alberta, Manitoba, New Brunswick, Newfoundland and Labrador, Ontario and Saskatchewan)